Loading viewer...
earnings
Format: PDF earnings
Third quarter fiscal 2023 earnings supplementary document presenting consolidated financial results. Net sales reached $2.2 billion with adjusted gross profit of $739.3 million, though margins contracted year-over-year.
other
29 Pages
earnings
23 Pages
ExOne Co
Alexion Pharmaceuticals Q2 2016 Earnings Call
earningsearnings
37 Pages
Alexion Pharmaceuticals
Axiata Group 2021 Results Presentation
earningsearnings
30 Pages
Axiata Group Berhad